You are here

Article info

Article menu

Download PDFPDF

Review
TAC-TIC use of tacrolimus-based regimens in lupus nephritis

Authors

  • Tineke Kraaij Department of Nephrology, Leiden University Medical Center, Leiden, The Netherlands Clinic for Lupus-, Vasculitis and Complement-Mediated Systemic Diseases, Leiden University Medical Center, Leiden, The Netherlands PubMed articlesGoogle scholar articles
  • Obbo W Bredewold Department of Nephrology, Leiden University Medical Center, Leiden, The Netherlands Clinic for Lupus-, Vasculitis and Complement-Mediated Systemic Diseases, Leiden University Medical Center, Leiden, The Netherlands PubMed articlesGoogle scholar articles
  • Stella Trompet Department of Gerontology and Geriatrics, Leiden University Medical Center, Leiden, The Netherlands Department of Cardiology, Leiden University Medical Center, Leiden, The Netherlands PubMed articlesGoogle scholar articles
  • Tom W J Huizinga Clinic for Lupus-, Vasculitis and Complement-Mediated Systemic Diseases, Leiden University Medical Center, Leiden, The Netherlands Department of Rheumatology, Leiden University Medical Center, Leiden, The Netherlands PubMed articlesGoogle scholar articles
  • Ton J Rabelink Department of Nephrology, Leiden University Medical Center, Leiden, The Netherlands Clinic for Lupus-, Vasculitis and Complement-Mediated Systemic Diseases, Leiden University Medical Center, Leiden, The Netherlands PubMed articlesGoogle scholar articles
  • Anton J M de Craen Department of Gerontology and Geriatrics, Leiden University Medical Center, Leiden, The Netherlands PubMed articlesGoogle scholar articles
  • Y K Onno Teng Department of Nephrology, Leiden University Medical Center, Leiden, The Netherlands Clinic for Lupus-, Vasculitis and Complement-Mediated Systemic Diseases, Leiden University Medical Center, Leiden, The Netherlands PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Y K Onno Teng; y.k.o.teng{at}lumc.nl
View Full Text

Citation

Kraaij T, Bredewold OW, Trompet S, et al
TAC-TIC use of tacrolimus-based regimens in lupus nephritis
Lupus Science & Medicine 2016;3:e000169. doi: 10.1136/lupus-2016-000169

Publication history

  • Received June 10, 2016
  • Revision received December 1, 2016
  • Accepted December 3, 2016
  • First published December 30, 2016.
Online issue publication 
May 01, 2020

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/ This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/